Drug General Information
Drug ID
D0S4MQ
Former ID
DNC012863
Drug Name
8-Bromo-6-styryl-naphthalene-2-carboxamidine
Drug Type
Small molecular drug
Indication Discovery agent Investigative [527320]
Formula
C19H15BrN2
Canonical SMILES
C1=CC=C(C=C1)C=CC2=CC(=C3C=C(C=CC3=C2)C(=N)N)Br
InChI
1S/C19H15BrN2/c20-18-11-14(7-6-13-4-2-1-3-5-13)10-15-8-9-16(19(21)22)12-17(15)18/h1-12H,(H3,21,22)/b7-6+
InChIKey
QHYGSRQJBXWIGI-VOTSOKGWSA-N
PubChem Compound ID
Target and Pathway
Target(s) Trypsin Target Info Inhibitor [527320]
KEGG Pathway Neuroactive ligand-receptor interaction
Pancreatic secretion
Protein digestion and absorption
Influenza A
Reactome Activation of Matrix Metalloproteinases
Cobalamin (Cbl, vitamin B12) transport and metabolism
WikiPathways Activation of Matrix Metalloproteinases
References
Ref 527320Bioorg Med Chem Lett. 2005 Jan 3;15(1):93-8.Naphthamidine urokinase plasminogen activator inhibitors with improved pharmacokinetic properties.
Ref 527320Bioorg Med Chem Lett. 2005 Jan 3;15(1):93-8.Naphthamidine urokinase plasminogen activator inhibitors with improved pharmacokinetic properties.